Term Sheet Templates & Complete Guide for Founders

A term sheet is a non-binding document outlining the key financial and governance terms of a proposed investment. It is the critical inflection point in a fundraise — the signal that an investor is serious enough to put specific deal terms on paper — and the blueprint for the definitive legal agreements that follow: the stock purchase agreement, investor rights agreement, voting agreement, and other closing documents.

Term sheets typically run 5 to 10 pages and cover economics (valuation, option pool, liquidation preference), control provisions (board composition, protective provisions, drag-along rights), and other terms (information rights, registration rights, no-shop).

According to data from Carta and PitchBook, the median time from signed term sheet to close is approximately 45 to 60 days, though seed rounds on standardized documents may close in as few as two weeks. Understand every line: these terms compound across rounds, and a bad precedent set at seed or Series A follows your cap table for the life of the company.

Founders often confuse term sheets with other pre-transaction documents, and the distinctions matter both legally and strategically. A term sheet is a non-binding summary of proposed investment terms; a letter of intent (LOI) is the analogous document in M&A and commercial transactions, though it often carries more extensive binding provisions around exclusivity, expense reimbursement, and break-up fees. In venture capital the two labels are sometimes used interchangeably, though purists reserve 'LOI' for acquisition contexts.

A memorandum of understanding (MOU) is a broader, more formal document used in commercial partnerships, joint ventures, and international agreements — and depending on jurisdiction and the parties' intent, a sufficiently detailed MOU can be interpreted as a binding contract. The definitive agreements — stock purchase agreement, investor rights agreement, voting agreement, ROFR/co-sale, and the amended certificate of incorporation — are the fully binding contracts that supersede the term sheet.

The term sheet's job is to align the parties before incurring the legal cost of drafting those documents — typically $30K-$75K for the company. One nuance: while term sheets are 'non-binding,' courts have occasionally found bad faith where a party walked away from a signed term sheet without legitimate cause, particularly when the company turned down other investors in reliance on it. Experienced founders keep backup options warm even after signing.

A standard venture capital term sheet is organized into a handful of major sections, each carrying clauses with significant implications for founders.

Every clause interacts with the others, which is why reviewing a term sheet clause-by-clause in isolation misses the full picture. A 'fair' valuation can be undermined by an aggressive liquidation preference and a large option pool increase carved out of the pre-money. Experienced founders and their counsel evaluate term sheets holistically.

Valuation is the headline number founders fixate on, but it is only meaningful in context with the other economic terms. Term sheets express a pre-money valuation (the company's value before the new investment) and a post-money valuation (pre-money plus the investment amount). Price per share is the pre-money valuation divided by the fully diluted share count — which usually includes the expanded option pool, a critical nuance covered in the next section.

Worked example: a company with a $20M pre-money raising $5M on 10M fully diluted shares prices at $2.00 per share ($20M / 10M). The investor receives 2.5M new shares ($5M / $2.00), the post-money is $25M, and the investor owns 10% ($5M / $25M).

Two term sheets at the same $20M pre-money can produce dramatically different founder ownership depending on option pool expansion, liquidation preference multiple, participation rights, and anti-dilution terms. Model the 'effective valuation' — your post-money ownership after all economic terms — not just the headline number. (Medians below vary widely by sector, geography, and market conditions.)

Most VC term sheets require the company to create or expand an employee option pool as a condition of closing, typically sized at 10-20% of post-money fully diluted shares. The critical detail is where the pool comes from: in nearly all VC deals it is carved out of the pre-money valuation, not the post-money. This is the 'option pool shuffle,' and it quietly reduces the true pre-money from the founder's perspective.

The math: take a $20M pre-money with a $5M investment ($25M post-money) and a required 15% post-money pool. That pool is worth $3.75M ($25M x 15%). Because it comes out of the pre-money, the effective pre-money for existing shareholders is $16.25M — founders and existing holders absorb the new pool's dilution entirely while the investor still pays the $20M price per share. The NVCA model makes this explicit by specifying that the pre-money valuation includes the expanded pool on a fully diluted basis.

To negotiate, push for the smallest pool you can justify with a credible 18-24 month hiring plan — titles, salaries, and equity grant ranges — and always compute the effective pre-money to compare term sheets accurately. An $18M pre-money with a 10% pool may actually beat a $20M pre-money with a 20% pool.

Liquidation preference determines who gets paid first — and how much — when a company is sold, merged, or wound down. After valuation, it is arguably the most economically significant term on the sheet.

The standard is '1x non-participating preferred': the investor receives the greater of (a) 1x their original investment or (b) their pro rata share as if converted to common. In a large exit they convert; in a small one, the preference guarantees their money back before common holders receive anything. Participating preferred — the 'double dip' — pays the 1x preference first AND a pro rata share of the remaining proceeds. Participation is sometimes capped at a specified multiple (e.g., 3x total).

The difference is dramatic. In a $50M exit where an investor put in $10M for 20%: non-participating yields $10M (20% of $50M = $10M, so they are indifferent), while participating yields $10M + 20% of the remaining $40M = $18M — an $8M swing out of common holders' pockets. Multiples above 1x (2x or 3x) have become rare outside distressed or late-stage deals. See /liquidation-preference-explained for a full walkthrough.

Anti-dilution provisions protect investors when a later financing prices below their original investment — a 'down round' — by adjusting their conversion price downward, which grants them additional common shares upon conversion.

Full ratchet resets the conversion price all the way to the new lower price regardless of how small the down round is — a tiny bridge note at a reduced price can completely reprice an entire Series A. Broad-based weighted average, the industry standard used in approximately 95% of institutional deals, adjusts proportionally to both the magnitude of the price drop and the relative size of the new issuance: small down rounds cause small repricing.

'Broad-based' matters because the formula's denominator includes all shares on a fully diluted basis — common, preferred, options, warrants, and the pool — producing a smaller, more founder-friendly adjustment than narrow-based (typically preferred shares only). Pay-to-play provisions, which require investors to participate in down rounds to keep their anti-dilution protection, are a useful counterweight. See /anti-dilution-explained for the full formula, worked examples, and negotiation playbook.

Dividend provisions specify whether preferred stockholders accrue dividends. The standard structure is 'non-cumulative dividends when, as, and if declared by the Board' — dividends are only paid if the board declares them, which almost never happens at a venture-backed startup. The clause is largely protective: if the company ever declares a dividend on common, preferred holders receive their share first (typically 6-8% annually on the original investment).

Cumulative dividends are different: they accrue whether or not the board declares them, typically at 6-8% per year, compounding annually and payable to preferred before any distribution to common — including at exit. Over a 5-7 year holding period, 8% cumulative dividends add 40-56% to the effective liquidation preference: a $10M investment held 7 years accrues $5.6M, making the effective preference $15.6M before common holders receive anything.

Cumulative structures have become less common in standard venture deals but appear in growth equity, late-stage rounds, and deals with strategic investors. Some term sheets use a 'PIK' (payment in kind) structure where accrued dividends are paid in additional shares — silent dilution over time. Push hard for non-cumulative.

Board composition determines who controls the company's strategic direction and is often the most contentious governance provision. The board approves major corporate actions: hiring and firing the CEO, approving budgets, authorizing new equity issuances, and deciding whether to accept acquisition offers.

Watch how the independent seat is selected. 'Mutually agreed' is standard — but a term sheet that lets preferred stockholders designate the independent director effectively hands investors board control from day one. Board observer rights let investors without a formal seat attend meetings and receive all board materials; observers cannot vote, but their presence shapes discussions and culture.

Most term sheets also cover board meeting cadence (minimum quarterly), D&O insurance requirements, and expense reimbursement for investor directors. Negotiate a provision preserving founder representation as new rounds add investor seats, and establish clear criteria for the independent director's qualifications and selection process.

Protective provisions give preferred stockholders (typically a majority or supermajority) veto power over specific corporate actions — in addition to board and common stockholder approval — so investors can block decisions that adversely affect their investment even when founders control the board.

The NVCA model includes approximately 10-12 standard provisions: issuing new equity senior to or on par with existing preferred, amending the certificate of incorporation to the preferred's detriment, changing the authorized share count, declaring or paying dividends, redeeming or repurchasing shares (other than at cost from departing employees), changing the principal line of business, selling the company or substantially all of its assets, incurring debt above a threshold (e.g., $250K), and changing board size.

These are standard and expected — the negotiation is scope. A provision requiring investor consent for any contract above $50K can make it nearly impossible to sign a major customer or vendor agreement without approval. Also watch the voting mechanics: all preferred voting 'as a single class' gives any one large investor less blocking power, while series-by-series voting can hand any single series a unilateral veto. The goal is legitimate protection against fundamental changes without impeding day-to-day operations.

Drag-along rights let a specified majority of shareholders (typically the board plus a majority of common and preferred voting together) force all shareholders to approve a company sale — solving the hold-up problem where a minority holder blocks an acquisition the majority supports. Negotiate the threshold: require both a majority of common and a majority of preferred, so neither group can drag the other unilaterally. Some term sheets add a minimum price threshold — the drag only activates above, say, 3x total invested capital — preventing investors from dragging founders into a fire-sale that pays the preference stack and leaves common with nothing.

Information rights require regular financial and operational reporting: annual audited financials, quarterly unaudited statements, monthly management reports, and an annual operating budget. They are reasonable and expected — investors owe their LPs visibility into portfolio companies. Negotiate delivery timing (e.g., quarterly statements within 45 days of quarter-end), the level of detail, and whether rights are limited to 'major investors' holding a minimum threshold (e.g., $1M+ in preferred stock).

Related asks include inspection rights (examining the company's books and records) and management rights letters, which institutional VCs need for regulatory compliance.

The National Venture Capital Association (NVCA) publishes the model legal documents that serve as the U.S. industry standard — virtually all major law firms draft from them. They are freely available at nvca.org and updated periodically to reflect evolving market practice.

The model term sheet walks through Offering Terms (security type, closing date, aggregate amount), Charter terms (dividends, liquidation preference, conversion mechanics, anti-dilution, pay-to-play, redemption), the Stock Purchase Agreement (representations and warranties, closing conditions, expense reimbursement), the Investor Rights Agreement (registration rights, information rights, ROFR on new issuances), the ROFR and Co-Sale Agreement (founder transfer restrictions), and the Voting Agreement (board composition, drag-along).

Its most valuable feature is the bracketed alternatives — [broad-based/narrow-based] for anti-dilution, [non-participating/participating/participating with cap] for liquidation preference — which make every negotiation point explicit, plus extensive footnotes explaining each provision's purpose and market context. Download the model documents before any negotiation: knowing the standard framework lets you spot deviations instantly, and counsel familiar with the NVCA models can benchmark your deal against market surveys from Fenwick & West, Cooley, and Wilson Sonsini.

Every term sheet requires negotiation, but certain provisions signal an adversarial investor relationship or economically punitive terms. The most cited: full ratchet anti-dilution, uncapped participating preferred, high cumulative dividends, and liquidation preference multiples above 1x.

Also watch for founder vesting resets (re-vesting from scratch can leave you with nothing if terminated early), overly broad protective provisions that hand the investor operational control, redemption rights letting investors force a share buyback at a specified date (typically 5-7 years) — a ticking debt obligation that can force a fire sale — unusually long no-shop periods (beyond 60 days), and 'ratchet' provisions tied to milestones, which grant investors additional shares if revenue or product targets slip and create misaligned incentives. On legal fees: the company paying the investor's costs is standard, but only with a cap (typically $25-50K).

Any of these should prompt a conversation with counsel about whether this investor is likely to be a constructive board member and partner.

Effective negotiation starts with your BATNA (Best Alternative to a Negotiated Agreement): do you have other term sheets, strong interest from other funds, or enough runway to walk away? Multiple term sheets are significant leverage; six months of runway and one interested investor is not.

Prioritize the 3-5 provisions that matter most — for most founders: valuation (including effective valuation after the option pool), liquidation preference (1x non-participating vs. participating), board composition, and anti-dilution type. Concede on less impactful terms. Use the NVCA model as your benchmark and ask investors to justify any deviation — those proposing non-standard terms should have a clear rationale. And engage experienced startup counsel early: firms like Cooley, Gunderson, Wilson Sonsini, Fenwick & West, and Goodwin negotiate these deals daily and know what is 'market' versus a reach.

Negotiate by phone or in person, not email — tone and relationship matter enormously. Frame pushbacks as alignment, not adversarial demands: instead of 'we won't accept participating preferred,' try 'we think 1x non-participating aligns us both toward a strong exit outcome.' Respond within 48-72 hours with one clear, organized markup rather than negotiating provision-by-provision over weeks. And remember these negotiations are often not zero-sum: founders care most about valuation and option pool, investors about governance and downside protection — ask what matters most to them and trade across those complementary priorities.

SAFEs and convertible notes still dominate pre-seed and small seed rounds under $2M — legal costs run $5-10K versus $25-50K for a priced round, and the process is faster. But priced seed rounds using preferred stock have become increasingly common at $2-5M+, particularly with institutional seed funds leading, using the Series Seed documents (open-source simplified financing docs maintained by Fenwick & West) or a simplified NVCA-based sheet. A priced round's advantage: a clear cap table from day one, which simplifies future fundraising.

Priced seed terms are shorter and simpler than Series A: 1x non-participating liquidation preference (virtually universal at seed), broad-based weighted average anti-dilution, no investor board seat (or a single observer), minimal protective provisions (often just 3-5 standard items rather than the full NVCA list), and no registration rights. Seed pre-money valuations typically run $8-15M depending on market, sector, and team; the option pool is usually 10-15% of post-money — smaller than the 15-20% typical at Series A. Pro rata rights for seed investors are standard and reasonable at any stage.

One seed-specific issue is founder vesting. Series A investors usually inherit existing vesting schedules, but seed investors sometimes negotiate for founders to restart or extend vesting. The standard is 4 years with a 1-year cliff — and founders who worked on the company pre-funding should receive credit for time served.

Series A is where term sheet complexity increases substantially. The lead is typically an institutional fund investing $5-15M, negotiating a full set of economic, governance, and protective terms off the NVCA baseline. Because the Series A sheet establishes the precedent for every future round, it is the most consequential term sheet a founder will negotiate.

Typical Series A economics (2025 market data): a pre-money valuation in the $25-50M range, 1x non-participating liquidation preference, broad-based weighted average anti-dilution, an option pool expansion to 15-20% of post-money shares, and non-cumulative dividends. Participation rights are uncommon but not unheard of — approximately 20% of deals include some form, usually capped at 2-3x.

On governance, the lead takes a board seat (typically a 3- or 5-person board with an independent director), negotiates full protective provisions plus monthly and quarterly reporting, and the investor rights agreement drafted here frames every future round — pay particular attention to the voting agreement's board seat allocation. The ROFR/co-sale agreement restricts founder secondary sales — shares must be offered to the company first, then to investors — preventing founders from cashing out ahead of their backers. Investor legal fee reimbursement is standard at a $25-50K cap (push back on uncapped provisions), the no-shop should be 30-45 days, and closing conditions must be achievable within the stated timeline.

Later-stage term sheets build on the Series A framework but add complexity from multiple investor classes, higher stakes, and more sophisticated structures. At Series B ($15-50M+ rounds at $100-300M+ pre-money in 2025), the new lead joins existing Series A investors, and the sheet must define how the new preferred series interacts with existing preferred stock.

The biggest structural issue is preference stacking: each series carries its own liquidation preference, typically paid in reverse chronological order — last money in, first money out. Raise $5M at Series A and $20M at Series B, both at 1x, and the first $25M of exit proceeds goes to preferred before common holders receive anything. That stacking can make moderate exits ($30-50M) nearly worthless for founders even when the headline sounds impressive.

Boards expand — a common Series B structure is 7 seats: 2 common, 3 investor, 2 independent — so founders must negotiate carefully to keep meaningful influence. Information rights may grow to include KPI dashboards and advance notice of material events. Pro rata rights decide the pecking order when oversubscribed rounds cut allocations. And later rounds may introduce milestone-based tranches (capital released in stages as targets are hit), redemption rights (forced repurchase after 5-7 years), and IPO ratchets (minimum-return guarantees at IPO) — all reflecting the larger capital at risk and investors' need to return capital to LPs within a fund's lifecycle.

Founders should plan for 4-8 weeks from signed term sheet to funds in the bank for a standard Series A. Seed rounds on SAFEs can close in as little as 1-2 weeks since no definitive agreements need drafting; Series B and later runs 6-10 weeks given multi-party negotiations and broader diligence scope.

Diligence delays usually trace to three issues: unclear IP assignment (did all founders and contractors sign invention assignment agreements?), cap table discrepancies (do SAFE conversion calculations match?), and employment law compliance (are contractors properly classified?). Even when the term sheet was clear, legal drafting surfaces issues requiring additional negotiation — this is normal and expected. Some deals close in a single day; others split signing and closing, with the wire arriving a few days after signing.

A well-organized venture capital term sheet follows a standard outline that experienced investors and founders recognize immediately, based on the NVCA model and common market practice.

Founders receiving their first term sheet should map each section to the explanations in this guide and discuss any unfamiliar term with counsel before responding.

The most common mistake is fixating on valuation while ignoring the economic terms that drive real outcomes. A $30M pre-money with 2x participating preferred and a 20% option pool expansion is worse for founders than a $22M pre-money with 1x non-participating and a 10% pool in virtually every exit scenario below $200M. Run the math on multiple exit scenarios before celebrating a headline number.

Second: engaging counsel too late. Startup-experienced counsel costs $500-700/hour but saves multiples of that in better terms and avoided pitfalls versus a general business attorney or DIY review. Third: underestimating relationship dynamics — the partner who sits on your board will be involved in every major decision for 7-10 years. Before signing, talk to founders of their other portfolio companies; an investor who is difficult during term sheet negotiation is showing you their board behavior.

Fourth: accepting terms because 'we can fix it in the next round.' This rarely happens — prior terms create a floor future investors will match and existing investors will defend. Fifth: co-founders negotiating without first aligning on priorities and red lines; conflicting signals weaken your position. Finally, many founders sign the no-shop without grasping its implications: during exclusivity you cannot solicit or accept competing offers, so if the deal falls through you have lost 30-60 days of fundraising momentum.